This week’s Trial of the Week features the Principal Investigator of the ATHOS-3 trial, Dr. Ashish Khanna.
Want to hear how excited Dr. Khanna was to see his name as first author in an NEJMN publication? He gives us a look behind the scenes of what goes into a large prospective RCT in the critically ill.
PLUS we review the history of angiotensin II, evidence before ATHOS-3, pertinent findings and considerations from the ATHOS-3 trial, research since, its optimal place in therapy, and much, much more.
Leave a comment